Current Multiple Myeloma Treatment Strategies with Novel Agents: A European PerspectiveHeinz Ludwig, Sonja Zweegman, Meral Beksaç et al.|The Oncologist|2010Cited by 92
Multiple Myeloma Treatment Strategies with Novel Agents in 2011: A European PerspectiveHeinz Ludwig, Antonio Palumbo, Meral Beksaç et al.|The Oncologist|2011Cited by 33
Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: use of "progression-free survival 2" as a clinical trial end-pointMeletios Α. Dimopoulos, A. Palumbo, MT Petrucci et al.|Haematologica|2015Cited by 30
Phase <scp>II</scp> study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: <scp>DSMM XI</scp> trialHermann Einsele, Stefan Knop, Wolfram Jung et al.|British Journal of Haematology|2017Cited by 30